Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New combo aims to stop early breast cancer in its tracks

NCT ID NCT05827081

Disease control Sponsor: Novartis Pharmaceuticals Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Sep 18, 2026 · Updated 25 times

Summary

This phase 3 trial is testing whether adding the targeted drug ribociclib to standard hormone therapy can help prevent invasive breast cancer from returning in people with HR+ HER2- early breast cancer. About 1,400 participants will receive the combination for up to 3 years. The main goal is to see how many remain cancer-free after 3 years.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Ribociclib (a targeted cancer drug) plus hormone therapy (letrozole, anastrozole, goserelin, or leuprolide)
What this could lead to
If successful, this combination could help prevent early breast cancer from coming back in patients with HR+ HER2- disease.
What could go wrong
This is an early-phase, single-arm study with no placebo group, so results may be less definitive. Side effects from ribociclib can include infections, fatigue, and liver issues.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 3

Large-scale testing in a bigger group. Usually the last step before a treatment can be approved.

Participants

About 1,400 people

The number the study aims to enrol. It can still change while the study runs.

Started

Feb 2024

Expected to finish

Sep 2030

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 100 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Key Inclusion criteria: * Participant is an adult, male or female ≥ 18 years of age at the time of informed consent form signature (IC). * Participant has a histologically and/or cytologically confirmed diagnosis of estrogen-receptor positive and/or progesterone receptor positive breast cancer (BC) based on the most recently analyzed tissue sample tested by a local laboratory prior to enrollment. * Participant has HER2- BC defined as a negative in situ hybridization test or an immunohistochemistry (IHC) status of 0, 1+ or 2+. If IHC is 2+, a negative in situ hybridization (FISH, CISH, or SISH) test is required by local laboratory testing based on the most recently analyzed tissue sample. * Participants may have already received any standard neoadjuvant and/or adjuvant ET, including tamoxifen or toremifene at the time of informed consent signature, but enrollment should occur within 36 months of prior ET start date and participants should have at least 3 years remaining of endocrine adjuvant therapy. * For participants with prior ET treatment \> 12 months, restaging is highly recommended (unless contradictory to local regulations) to rule out disease recurrence prior to enrollment. * The number of participants with prior ET between 12 and 36 months will be capped at 30%. The cap will not apply to Black or African American participants. * Participant has no contraindication to receive adjuvant ET in the study. * Participant after surgical resection where tumor was removed completely, with the final surgical specimen microscopic margins free from tumor, and belongs to one of the following categories: * Anatomic Stage Group III, or * Anatomic Stage Group IIB, or * A subset of Anatomic Stage Group IIA. * Participant has an Eastern Cooperative Oncology Group (ECOG) Performance Status of 0, 1 or 2. * Participant has adequate bone marrow and organ function. * ECG values assessed by KardiaMobile-6L device, or standard 12-lead ECG per local investigator where KardiaMobile-6L cannot be used, as: * QTcF interval at Screening \< 450 msec (QT interval using Fridericia's correction). * Mean resting heart rate 50-99 beats per minute (determined from the ECG). Key Exclusion criteria: * Participant with distant metastases of BC beyond regional lymph nodes (Stage IV according to AJCC 8th edition) and/or evidence of recurrence after curative surgery. * Participant is concurrently using other antineoplastic therapy with the exception of adjuvant ET. * Participant has any other concurrent severe and/or uncontrolled medical condition that would, in the Investigator's judgment, cause unacceptable safety risks, contraindicate participant participation in the clinical study or compromise compliance with the protocol, or limit life expectancy to ≤5 years. * Clinically significant, uncontrolled heart disease and/or cardiac repolarization abnormality. * Pregnant or breast-feeding (lactating) women or women who plan to become pregnant or breast-feed during the trial. * Women of child-bearing potential (CBP), defined as all women physiologically capable of becoming pregnant, unless they are using highly effective methods of contraception while taking study treatment and for 21 days after stopping the treatment. Other inclusion/exclusion criteria may apply

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Early breast cancer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm hormone receptor-positive breast cancer male breast carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Early breast cancer

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    118 sites in 9 countries. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • AdventHealth Altamonte Springs

    ACTIVE_NOT_RECRUITING

    Altamonte Springs, Florida, 32701, United States

  • AdventHealth Medical Group Hematology and Oncology

    WITHDRAWN

    Denver, Colorado, 80210, United States

  • Affiliated Oncologists IL

    RECRUITING

    Chicago, Illinois, 60415, United States

  • Alaska Oncology and Hematology LLC

    RECRUITING

    Anchorage, Alaska, 99508, United States

  • Allegheny Health Network

    RECRUITING

    Pittsburgh, Pennsylvania, 15212, United States

  • Allina Hlth Cancer Inst Minneapolis

    RECRUITING

    Minneapolis, Minnesota, 55407, United States

  • Beverly Hills Cancer Center

    ACTIVE_NOT_RECRUITING

    Beverly Hills, California, 90211, United States

  • Bon Secours St Francis Cancer Center

    RECRUITING

    Greenville, South Carolina, 29607, United States

  • Bon Secours Virginia Health System

    RECRUITING

    Midlothian, Virginia, 23114, United States

  • Boston Medical Center

    ACTIVE_NOT_RECRUITING

    Boston, Massachusetts, 02118, United States

  • CARTI Cancer Center

    RECRUITING

    Little Rock, Arkansas, 72205, United States

  • Cancer Care Specialists

    RECRUITING

    Reno, Nevada, 89511, United States

  • Cancer Center of Kansas

    RECRUITING

    Wichita, Kansas, 67214-3728, United States

  • Central Alabama Research

    RECRUITING

    Birmingham, Alabama, 35209, United States

  • City of Hope National Medical

    RECRUITING

    Duarte, California, 91010, United States

  • Cone Health Cancer Center

    RECRUITING

    Greensboro, North Carolina, 27403, United States

  • Consultants In Med Onco And Hema

    RECRUITING

    Drexel Hill, Pennsylvania, 19026, United States

  • Dana Farber Brigham Women Cancer

    WITHDRAWN

    Milford, Massachusetts, 01757, United States

  • Dana Farber Cancer Institute

    RECRUITING

    Boston, Massachusetts, 02215, United States

  • Duke Cancer Network

    RECRUITING

    Durham, North Carolina, 27710, United States

  • El Camino Hospital

    RECRUITING

    Mountain View, California, 94040, United States

  • El Paso Texas Oncology

    RECRUITING

    El Paso, Texas, 79902, United States

  • Georgetown University Lombardi Cancer Center

    RECRUITING

    Washington D.C., District of Columbia, 20007-2197, United States

  • Good Samaritan Regional Medical Center

    RECRUITING

    Corvallis, Oregon, 97330, United States

  • HCA Midwest Division

    RECRUITING

    Kansas City, Missouri, 64132, United States

  • Hawaii Cancer Care

    WITHDRAWN

    Honolulu, Hawaii, 96813, United States

  • Hialeah Hospital

    RECRUITING

    Hialeah, Florida, 33013, United States

  • Holy Cross Health

    RECRUITING

    Fort Lauderdale, Florida, 33308, United States

  • Hope And Healing Care

    RECRUITING

    Hinsdale, Illinois, 60521, United States

  • Intermountain Healthcare

    RECRUITING

    Billings, Montana, 59102, United States

  • Investigative Clinical R of Indiana

    RECRUITING

    Indianapolis, Indiana, 46260, United States

  • Jackson Oncology Associates

    RECRUITING

    Jackson, Mississippi, 39202, United States

  • Jupiter Medical Center

    RECRUITING

    Jupiter, Florida, 33458, United States

  • Kadlec Clinic Hematology and Onco

    RECRUITING

    Kennewick, Washington, 99336, United States

  • Kelsey Seybold Clinic

    RECRUITING

    Houston, Texas, 77025, United States

  • Lexington Medical Center

    WITHDRAWN

    West Columbia, South Carolina, 29169, United States

  • Los Angeles Cancer Network Good Samaritan

    RECRUITING

    Los Angeles, California, 90017, United States

  • MD Anderson Cancer Center At Cooper

    RECRUITING

    Camden, New Jersey, 08103, United States

  • Maryland Oncology Hematology P A

    RECRUITING

    Silver Spring, Maryland, 20904, United States

  • Medical College of Wisconsin

    RECRUITING

    Milwaukee, Wisconsin, 53226, United States

  • Medstar Washington Hospital Center

    RECRUITING

    Washington D.C., District of Columbia, 20010, United States

  • Memorial Cancer Institute

    RECRUITING

    Hollywood, Florida, 33021, United States

  • Mercy Medical Center

    RECRUITING

    Baltimore, Maryland, 21202, United States

  • Midwestern Reg MC COH Chicago

    RECRUITING

    Zion, Illinois, 60099, United States

  • Minnesota Oncology Hematology P A

    RECRUITING

    Minneapolis, Minnesota, 55404, United States

  • Mount Sinai School of Medicine

    RECRUITING

    New York, New York, 10029, United States

  • Nebraska Cancer Specialists

    RECRUITING

    Omaha, Nebraska, 68154, United States

  • Northwest Cancer Specialists

    RECRUITING

    Portland, Oregon, 97210, United States

  • Northwest Medical Specialties

    RECRUITING

    Tacoma, Washington, 98405, United States

  • Novartis Investigative Site

    ACTIVE_NOT_RECRUITING

    Caba, Buenos Aires, C1426ANZ, Argentina

  • Novartis Investigative Site

    RECRUITING

    La Plata, Buenos Aires, B1902CMV, Argentina

  • Novartis Investigative Site

    RECRUITING

    Córdoba, X5004BAL, Argentina

  • Novartis Investigative Site

    ACTIVE_NOT_RECRUITING

    Gateshead, New South Wales, 2290, Australia

  • Novartis Investigative Site

    ACTIVE_NOT_RECRUITING

    Tiwi, Northern Territory, 0810, Australia

  • Novartis Investigative Site

    ACTIVE_NOT_RECRUITING

    Clayton, Victoria, 3168, Australia

  • Novartis Investigative Site

    ACTIVE_NOT_RECRUITING

    East Melbourne, Victoria, 3002, Australia

  • Novartis Investigative Site

    RECRUITING

    Salvador, Estado de Bahia, 40170-110, Brazil

  • Novartis Investigative Site

    RECRUITING

    Belo Horizonte, Minas Gerais, 30220-140, Brazil

  • Novartis Investigative Site

    RECRUITING

    Porto Alegre, Rio Grande do Sul, 90470-340, Brazil

  • Novartis Investigative Site

    RECRUITING

    Porto Alegre, Rio Grande do Sul, 90560-032, Brazil

  • Novartis Investigative Site

    RECRUITING

    Porto Alegre, Rio Grande do Sul, 90610-000, Brazil

  • Novartis Investigative Site

    RECRUITING

    São Paulo, São Paulo, 04502-001, Brazil

  • Novartis Investigative Site

    RECRUITING

    São Paulo, São Paulo, 05652-000, Brazil

  • Novartis Investigative Site

    RECRUITING

    Rio de Janeiro, 22281-100, Brazil

  • Novartis Investigative Site

    RECRUITING

    Rio de Janeiro, 22775-001, Brazil

  • Novartis Investigative Site

    RECRUITING

    São Paulo, 01323-000, Brazil

  • Novartis Investigative Site

    ACTIVE_NOT_RECRUITING

    Victoria, British Columbia, V8R 6V5, Canada

  • Novartis Investigative Site

    ACTIVE_NOT_RECRUITING

    Halifax, Nova Scotia, B3H 2Y9, Canada

  • Novartis Investigative Site

    ACTIVE_NOT_RECRUITING

    Oakville, Ontario, L6M 1M1, Canada

  • Novartis Investigative Site

    ACTIVE_NOT_RECRUITING

    Ottawa, Ontario, K1H 8L6, Canada

  • Novartis Investigative Site

    RECRUITING

    Toronto, Ontario, M4N 3M5, Canada

  • Novartis Investigative Site

    RECRUITING

    Toronto, Ontario, M5T 3L9, Canada

  • Novartis Investigative Site

    ACTIVE_NOT_RECRUITING

    Montreal, Quebec, H2X 0A9, Canada

  • Novartis Investigative Site

    RECRUITING

    Montreal, Quebec, H3T 1E2, Canada

  • Novartis Investigative Site

    RECRUITING

    Montreal, Quebec, H4A 3J1, Canada

  • Novartis Investigative Site

    RECRUITING

    Québec, Quebec, G1S 4L8, Canada

  • Novartis Investigative Site

    ACTIVE_NOT_RECRUITING

    Saskatoon, Saskatchewan, S7N 4H4, Canada

  • Novartis Investigative Site

    ACTIVE_NOT_RECRUITING

    Beijing, Beijing Municipality, 100044, China

  • Novartis Investigative Site

    ACTIVE_NOT_RECRUITING

    Guangzhou, Guangdong, 510080, China

  • Novartis Investigative Site

    RECRUITING

    Harbin, Heilongjiang, 150081, China

  • Novartis Investigative Site

    ACTIVE_NOT_RECRUITING

    Zhengzhou, Henan, 450003, China

  • Novartis Investigative Site

    ACTIVE_NOT_RECRUITING

    Zhengzhou, Henan, 450008, China

  • Novartis Investigative Site

    RECRUITING

    Nanjing, Jiangsu, 210029, China

  • Novartis Investigative Site

    ACTIVE_NOT_RECRUITING

    Nanchang, Jiangxi, 330009, China

  • Novartis Investigative Site

    ACTIVE_NOT_RECRUITING

    Changchun, Jilin, 130021, China

  • Novartis Investigative Site

    ACTIVE_NOT_RECRUITING

    Jinan, Shandong, 250021, China

  • Novartis Investigative Site

    ACTIVE_NOT_RECRUITING

    Jinan, Shandong, 250117, China

  • Novartis Investigative Site

    ACTIVE_NOT_RECRUITING

    Jining, Shandong, 272000, China

  • Novartis Investigative Site

    ACTIVE_NOT_RECRUITING

    Chengdu, Sichuan, 610041, China

  • Novartis Investigative Site

    ACTIVE_NOT_RECRUITING

    Chengdu, Sichuan, 610072, China

  • Novartis Investigative Site

    ACTIVE_NOT_RECRUITING

    Ürümqi, Xinjiang, 830000, China

  • Novartis Investigative Site

    ACTIVE_NOT_RECRUITING

    Hangzhou, Zhejiang, 310006, China

  • Novartis Investigative Site

    ACTIVE_NOT_RECRUITING

    Hangzhou, Zhejiang, 310022, China

  • Novartis Investigative Site

    ACTIVE_NOT_RECRUITING

    Wenzhou, Zhejiang, 325000, China

  • Novartis Investigative Site

    ACTIVE_NOT_RECRUITING

    Beijing, 100039, China

  • Novartis Investigative Site

    ACTIVE_NOT_RECRUITING

    Beijing, 100730, China

  • Novartis Investigative Site

    RECRUITING

    Guangzhou, 510060, China

  • Novartis Investigative Site

    ACTIVE_NOT_RECRUITING

    Qingdao, 266000, China

  • Novartis Investigative Site

    ACTIVE_NOT_RECRUITING

    Shanghai, 200032, China

  • Novartis Investigative Site

    ACTIVE_NOT_RECRUITING

    Shijiazhuang, 050035, China

  • Novartis Investigative Site

    ACTIVE_NOT_RECRUITING

    Tianjin, 300480, China

  • Novartis Investigative Site

    ACTIVE_NOT_RECRUITING

    Freiburg im Breisgau, Baden-Wurttemberg, 79106, Germany

  • Novartis Investigative Site

    ACTIVE_NOT_RECRUITING

    Munich, Bavaria, 81377, Germany

  • Novartis Investigative Site

    ACTIVE_NOT_RECRUITING

    Regensburg, Bavaria, 93053, Germany

  • Novartis Investigative Site

    ACTIVE_NOT_RECRUITING

    Weiden in Der Oberpfalz, Bavaria, 92637, Germany

  • Novartis Investigative Site

    ACTIVE_NOT_RECRUITING

    Langen, Hesse, 63225, Germany

  • Novartis Investigative Site

    WITHDRAWN

    Hildesheim, Lower Saxony, 31134, Germany

  • Novartis Investigative Site

    ACTIVE_NOT_RECRUITING

    Bergisch Gladbach, North Rhine-Westphalia, 51465, Germany

  • Novartis Investigative Site

    WITHDRAWN

    Bielefeld, North Rhine-Westphalia, 33604, Germany

  • Novartis Investigative Site

    WITHDRAWN

    Düsseldorf, North Rhine-Westphalia, 40225, Germany

  • Novartis Investigative Site

    ACTIVE_NOT_RECRUITING

    Essen, North Rhine-Westphalia, 45136, Germany

  • Novartis Investigative Site

    ACTIVE_NOT_RECRUITING

    Mönchengladbach, North Rhine-Westphalia, 41061, Germany

  • Novartis Investigative Site

    ACTIVE_NOT_RECRUITING

    Velbert, North Rhine-Westphalia, 42551, Germany

  • Novartis Investigative Site

    ACTIVE_NOT_RECRUITING

    Dresden, Saxony, 01307, Germany

  • Novartis Investigative Site

    WITHDRAWN

    Lübeck, Schleswig-Holstein, 23563, Germany

  • Novartis Investigative Site

    RECRUITING

    Augsburg, 86150, Germany

  • Novartis Investigative Site

    ACTIVE_NOT_RECRUITING

    Augsburg, 86179, Germany

  • Novartis Investigative Site

    ACTIVE_NOT_RECRUITING

    Berlin, 10967, Germany

  • Novartis Investigative Site

    WITHDRAWN

    Berlin, 13125, Germany

  • Novartis Investigative Site

    ACTIVE_NOT_RECRUITING

    Bottrop, 46236, Germany

  • Novartis Investigative Site

    WITHDRAWN

    Böblingen, 71032, Germany

  • Novartis Investigative Site

    ACTIVE_NOT_RECRUITING

    Dessau, 06847, Germany

  • Novartis Investigative Site

    ACTIVE_NOT_RECRUITING

    Erlangen, 91054, Germany

  • Novartis Investigative Site

    ACTIVE_NOT_RECRUITING

    Essen, 45147, Germany

  • Novartis Investigative Site

    WITHDRAWN

    Hamburg, 20246, Germany

  • Novartis Investigative Site

    ACTIVE_NOT_RECRUITING

    Kiel, 24105, Germany

  • Novartis Investigative Site

    ACTIVE_NOT_RECRUITING

    Leipzig, 04277, Germany

  • Novartis Investigative Site

    WITHDRAWN

    Mainz, 55131, Germany

  • Novartis Investigative Site

    ACTIVE_NOT_RECRUITING

    München, 80637, Germany

  • Novartis Investigative Site

    ACTIVE_NOT_RECRUITING

    Ravensburg, 88214, Germany

  • Novartis Investigative Site

    ACTIVE_NOT_RECRUITING

    Hong Kong, 999077, Hong Kong

  • Novartis Investigative Site

    ACTIVE_NOT_RECRUITING

    Kowloon, 999077, Hong Kong

  • Novartis Investigative Site

    ACTIVE_NOT_RECRUITING

    Tuenmen, 999077, Hong Kong

  • Novartis Investigative Site

    ACTIVE_NOT_RECRUITING

    Hyderabad, Andhra Pradesh, 500034, India

  • Novartis Investigative Site

    ACTIVE_NOT_RECRUITING

    Bangalore, Karnataka, 560017, India

  • Novartis Investigative Site

    ACTIVE_NOT_RECRUITING

    Mumbai, Maharashtra, 400012, India

  • Novartis Investigative Site

    ACTIVE_NOT_RECRUITING

    Pune, Maharasthra, 411028, India

  • Novartis Investigative Site

    ACTIVE_NOT_RECRUITING

    New Delhi, National Capital Territory of Delhi, 110029, India

  • Novartis Investigative Site

    ACTIVE_NOT_RECRUITING

    Bhubaneswar, Odisha, 751007, India

  • Novartis Investigative Site

    ACTIVE_NOT_RECRUITING

    Chennai, Tamil Nadu, 600035, India

  • Novartis Investigative Site

    ACTIVE_NOT_RECRUITING

    Kolkata, West Bengal, 700054, India

  • Novartis Investigative Site

    ACTIVE_NOT_RECRUITING

    Ahmedabad, 380054, India

  • Novartis Investigative Site

    ACTIVE_NOT_RECRUITING

    Beersheba, 8457108, Israel

  • Novartis Investigative Site

    ACTIVE_NOT_RECRUITING

    Petah Tikva, 4941492, Israel

  • Novartis Investigative Site

    ACTIVE_NOT_RECRUITING

    Ramat Gan, 5265601, Israel

  • Novartis Investigative Site

    ACTIVE_NOT_RECRUITING

    Tel Aviv, 6423906, Israel

  • Novartis Investigative Site

    WITHDRAWN

    Alc Cuahutemoc, Mexico City, 06720, Mexico

  • Novartis Investigative Site

    RECRUITING

    Tlalpan, Mexico City, 14080, Mexico

  • Novartis Investigative Site

    RECRUITING

    Monterrey, Nuevo León, 64460, Mexico

  • Novartis Investigative Site

    ACTIVE_NOT_RECRUITING

    Coimbra, 3000-075, Portugal

  • Novartis Investigative Site

    ACTIVE_NOT_RECRUITING

    Lisbon, 1400-038, Portugal

  • Novartis Investigative Site

    ACTIVE_NOT_RECRUITING

    Lisbon, 1649-035, Portugal

  • Novartis Investigative Site

    ACTIVE_NOT_RECRUITING

    Porto, 4100-180, Portugal

  • Novartis Investigative Site

    ACTIVE_NOT_RECRUITING

    Porto, 4200-072, Portugal

  • Novartis Investigative Site

    ACTIVE_NOT_RECRUITING

    Porto, 4200-319, Portugal

  • Novartis Investigative Site

    ACTIVE_NOT_RECRUITING

    Bundang Gu, Gyeonggi-do, 13620, South Korea

  • Novartis Investigative Site

    ACTIVE_NOT_RECRUITING

    Gyeonggi-do, Korea, 10408, South Korea

  • Novartis Investigative Site

    ACTIVE_NOT_RECRUITING

    Incheon, Korea, 405 760, South Korea

  • Novartis Investigative Site

    ACTIVE_NOT_RECRUITING

    Seoul, Korea, 02841, South Korea

  • Novartis Investigative Site

    ACTIVE_NOT_RECRUITING

    Seoul, Yangcheon Gu, 07985, South Korea

  • Novartis Investigative Site

    ACTIVE_NOT_RECRUITING

    Seongnam Gyeonggi, 463-712, South Korea

  • Novartis Investigative Site

    ACTIVE_NOT_RECRUITING

    Seoul, 03080, South Korea

  • Novartis Investigative Site

    ACTIVE_NOT_RECRUITING

    Seoul, 03722, South Korea

  • Novartis Investigative Site

    ACTIVE_NOT_RECRUITING

    Seoul, 05505, South Korea

  • Novartis Investigative Site

    ACTIVE_NOT_RECRUITING

    Seoul, 06273, South Korea

  • Novartis Investigative Site

    ACTIVE_NOT_RECRUITING

    Seoul, 06351, South Korea

  • Novartis Investigative Site

    ACTIVE_NOT_RECRUITING

    Seoul, 06591, South Korea

  • Novartis Investigative Site

    ACTIVE_NOT_RECRUITING

    Hualien City, 970, Taiwan

  • Novartis Investigative Site

    ACTIVE_NOT_RECRUITING

    Kaohsiung City, 80756, Taiwan

  • Novartis Investigative Site

    ACTIVE_NOT_RECRUITING

    Tainan, 71004, Taiwan

  • Novartis Investigative Site

    ACTIVE_NOT_RECRUITING

    Taipei, 10002, Taiwan

  • Novartis Investigative Site

    ACTIVE_NOT_RECRUITING

    Taipei, 11490, Taiwan

  • Novartis Investigative Site

    RECRUITING

    Sakarya, Adapazari, 54290, Turkey (Türkiye)

  • Novartis Investigative Site

    RECRUITING

    Ankara, Bilkent-Cankaya, 06800, Turkey (Türkiye)

  • Novartis Investigative Site

    RECRUITING

    Istanbul, Fatih, 34098, Turkey (Türkiye)

  • Novartis Investigative Site

    RECRUITING

    Istanbul, Kadikoy, 34722, Turkey (Türkiye)

  • Novartis Investigative Site

    RECRUITING

    Izmir, Karsiyaka, 35575, Turkey (Türkiye)

  • Novartis Investigative Site

    RECRUITING

    Denizli, Kinikli, 20070, Turkey (Türkiye)

  • Novartis Investigative Site

    RECRUITING

    Antalya, Konyaalti, 07070, Turkey (Türkiye)

  • Novartis Investigative Site

    RECRUITING

    Istanbul, Sariyer, 34457, Turkey (Türkiye)

  • Novartis Investigative Site

    RECRUITING

    Ankara, Sihhiye-Altindag, 06230, Turkey (Türkiye)

  • Novartis Investigative Site

    RECRUITING

    Diyarbakır, Sur, 21280, Turkey (Türkiye)

  • Novartis Investigative Site

    RECRUITING

    Istanbul, Uskudar, 34662, Turkey (Türkiye)

  • Novartis Investigative Site

    RECRUITING

    Ankara, Yenimahalle, 06200, Turkey (Türkiye)

  • Novartis Investigative Site

    RECRUITING

    Ankara, Yenimahalle, 06500, Turkey (Türkiye)

  • Novartis Investigative Site

    RECRUITING

    Adana, Yuregir, 01230, Turkey (Türkiye)

  • Novartis Investigative Site

    RECRUITING

    Ankara, 06520, Turkey (Türkiye)

  • Novartis Investigative Site

    RECRUITING

    Istanbul, 34147, Turkey (Türkiye)

  • Novartis Investigative Site

    RECRUITING

    Izmir, 35100, Turkey (Türkiye)

  • Novartis Investigative Site

    RECRUITING

    Kecioren Ankara, 06010, Turkey (Türkiye)

  • Novartis Investigative Site

    ACTIVE_NOT_RECRUITING

    Konya, 42080, Turkey (Türkiye)

  • Novartis Investigative Site

    RECRUITING

    Samsun, 55200, Turkey (Türkiye)

  • Ocala Research Institute, Inc

    RECRUITING

    Ocala, Florida, 34474, United States

  • Onco Inst of Hope and Innovation

    RECRUITING

    Cerritos, California, 90703, United States

  • Oncology Associates of Oregon PC

    RECRUITING

    Eugene, Oregon, 97401-8122, United States

  • Optum Health

    RECRUITING

    Lake Success, New York, 11042, United States

  • Oregon Oncology Specialists Salem

    RECRUITING

    Salem, Oregon, 97301, United States

  • Palo Alto Medical Foundation

    RECRUITING

    Mountain View, California, 94040, United States

  • Pan Oncology

    RECRUITING

    Rio Piedras, 00935, Puerto Rico

  • Presbyterian Medical Group

    RECRUITING

    Albuquerque, New Mexico, 87110, United States

  • Providence Medical Foundation

    RECRUITING

    Fullerton, California, 92835, United States

  • Providence Regional Cancer System

    RECRUITING

    Lacey, Washington, 98503, United States

  • Queens Cancer Center of Queens Hospital

    RECRUITING

    Jamaica, New York, 11432, United States

  • Regional Medical Oncology NC

    WITHDRAWN

    Wilson, South Carolina, 27893, United States

  • Renown Regional Medical Center

    ACTIVE_NOT_RECRUITING

    Reno, Nevada, 89502, United States

  • Rhode Island Hospital

    RECRUITING

    Providence, Rhode Island, 02903, United States

  • Rocky Mountain Cancer Centers

    RECRUITING

    Denver, Colorado, 80218, United States

  • Sanford Research USD Fargo

    RECRUITING

    Fargo, North Dakota, 58122, United States

  • Sanford USD Medical Center

    RECRUITING

    Sioux Falls, South Dakota, 57104, United States

  • Sarah Cannon Research Institute

    RECRUITING

    Nashville, Tennessee, 37203, United States

  • School Of Medicine

    RECRUITING

    Sacramento, California, 95817, United States

  • Sharp Rees Stealy Medical Group Inc

    RECRUITING

    San Diego, California, 92101, United States

  • Summit Cancer Care PC

    RECRUITING

    Savannah, Georgia, 31405, United States

  • Summit Health

    RECRUITING

    Florham Park, New Jersey, 07932, United States

  • Sutter Inst Medical Research

    RECRUITING

    Sacramento, California, 95816-5199, United States

  • Texas Oncology P A Plano East

    RECRUITING

    Plano, Texas, 75075, United States

  • Texas Oncology PA Tyler

    RECRUITING

    Tyler, Texas, 75702, United States

  • The Valley Hospital

    RECRUITING

    Ridgewood, New Jersey, 07450, United States

  • UC Irvine Medical Center

    RECRUITING

    Orange, California, 92868, United States

  • Univ of Pittsburg Med Ctr Pinnacle

    RECRUITING

    Harrisburg, Pennsylvania, 17109, United States

  • University Cancer and Blood Center LLC

    WITHDRAWN

    Athens, Georgia, 30607, United States

  • University of Iowa Health Care

    RECRUITING

    Waukee, Iowa, 50263, United States

  • University of Kansas Cancer Center

    RECRUITING

    Westwood, Kansas, 66205, United States

  • University of Texas

    RECRUITING

    Houston, Texas, 77030-4099, United States

  • Valley Medical Center Research

    RECRUITING

    Renton, Washington, 98055, United States

  • Virginia Oncology Associates

    RECRUITING

    Norfolk, Virginia, 23502, United States

  • WA Uni School Of Med

    RECRUITING

    St Louis, Missouri, 63110, United States

  • Western Reg MC-COH Phoenix

    RECRUITING

    Goodyear, Arizona, 85338, United States

  • Willis-Knighton Cancer Center

    RECRUITING

    Shreveport, Louisiana, 71103, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.